Alternative donor transplants for leukemia. Scientific Advisory Committee of the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1993;11 Suppl 1:66-7
Date
01/01/1993Pubmed ID
8448552Scopus ID
2-s2.0-0027523646 (requires institutional sign-in at Scopus site) 3 CitationsAbstract
We analyzed transplant outcome in more than 2,500 recipients of alternative donor and HLA-identical sibling transplants. These data indicate: (1) results of alternative donor transplants are inferior to HLA-identical sibling transplants; (2) zero HLA-antigen disparate unrelated and one HLA-antigen disparate related donors have comparable results; (3) amongst unrelated donors, zero and one HLA-antigen disparity has comparable results; and (4), amongst related transplants, two HLA-antigen disparate transplants fare worse than one HLA-antigen disparate transplants. These data should be useful in deciding when to use an alternative donor and selecting the best donor.
Author List
Gale RP, Horowitz MMAuthor
Mary M. Horowitz MD, MS Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Bone Marrow TransplantationHLA Antigens
Histocompatibility
Humans
Leukemia
Multivariate Analysis
Tissue Donors